Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...

As a result, the muscles become weak when a person performs repeated physical movements. The disease is neither contagious nor inherited but it is often misunderstood as a psychological issue or ...

flare-ups of intestinal diseases, such as ulcerative colitis flare-ups of nervous system disorders, such as multiple sclerosis or myasthenia gravis certain ... you have severe symptoms ...

Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.

The centre will offer advanced blood tests that can identify risk as early as age 40.

Myasthenia gravis is a serious, rare, and chronic neuromuscular autoimmune disease that can cause debilitating and potentially life-threatening muscle weakness. There are around 60,000 to 120,000 ...

Common symptoms include chronic diarrhea, abdominal pain, and unintended weight loss. Crohn’s Disease can lead to complications beyond the gut, such as skin problems, joint pain, and bowel ...

In the Phase III SELECT-GCA trial, Rinvoq (upadacitinib) 15 mg with a 26-week glucocorticoid taper significantly improved ...